Virtual Library

Start Your Search

  • ACLC 2018

    IASLC Asia Conference on Lung Cancer 2018

    Access Abstracts and Powerpoint Slides to select presentations that took place during the IASLC Asia Conference on Lung Cancer 2018 in Guangzhou, China from November 8 - 10, 2018. This package is available for no charge to active IASLC Members.

    Presentation Date(s):  
    • November 8 - 10, 2018
    • Total Presentations: 137

Filter Results:

Show Only Available Presentations

  • +

    Poster Session (ID 8)

    • Type: Poster Session
    • Track:
    • Presentations: 90
    • +

      P001 - Discrepancy of Oncogenic Mutations in Bone Metastasis Derived from Lung Adenocarcinoma (ID 104)

      00:00 - 00:00  |  Author(s): L. Huang, A. Liu

      • Abstract

      Loading...

    • +

      P002 - Surgical Resection Improves the Survival of (ID 134)

      00:00 - 00:00  |  Author(s): B. Zhang, Q. Xiao

      • Abstract

      Loading...

    • +

      P003 - Prognosis of Advanced Lung Cancer by Age Groups : A SEER Database Analysis (ID 71)

      00:00 - 00:00  |  Author(s): B. Wang, J. Liu

      • Abstract

      Loading...

    • +

      P006 - Evaluation of Efficacy and Safety of Uniportal Segmentectomy in the Treatment of Small Lung Nodule (ID 125)

      00:00 - 00:00  |  Author(s): C. Zhang, G. Wang, Z. Yu, H. Liu, H. Liu

      • Abstract

      Loading...

    • +

      P008 - Correlation Between Genetic Mutation State and Cancer-Associated Thrombosis in Advanced Cancer Patients (ID 33)

      00:00 - 00:00  |  Author(s): X. Zhang, Z. Wang, D. Jiang

      • Abstract

      Loading...

    • +

      P011 - Concurrent ALK/EGFR Alterations in Chinese Lung Cancers: Frequency, Clinical Features, and Differential Response to Therapy (ID 152)

      00:00 - 00:00  |  Author(s): D. Wu, J. Liu, Z. Mu, L. Liu, K. Li, R. Jiang, P. Chen, Q. Zhou, M. Jin, Y. Ma, Y. Xie, J. Xiang, T. Zhang, B. Li, B. Yu

      • Abstract

      Loading...

    • +

      P012 - Pooled Safety Analysis for Two Generations ALK Inhibitors: A Meta Analysis (ID 31)

      00:00 - 00:00  |  Author(s): D. Sun, H. Hou, X. Zhang

      • Abstract

      Loading...

    • +

      P013 - Anti-PD-1 Combination (ID 85)

      00:00 - 00:00  |  Author(s): F. Zhang, D. Huang, L. Li, J. Ma, J. Wang, S. Jiao, Y. Hu

      • Abstract

      Loading...

    • +

      P015 - Motion Management Without Fiducial Tracking Using Cyberknife SBRT (ID 10)

      00:00 - 00:00  |  Author(s): G. Lohith, S. Varun Kumar, S. Shwetha, P. Anuradha

      • Abstract

      Loading...

    • +

      P016 - The Optimal ALK inhibitor in Advanced ALK-Positive NSCLC Patients: An Indirect Comparison Between Brigatinib and Alectinib (ID 224)

      00:00 - 00:00  |  Author(s): H Zhou

      • Abstract

      Loading...

    • +

      P017 - Investigation of Mediastinal Lymph Node Metastasis in Non-Small Cell Lung Cancer (ID 72)

      00:00 - 00:00  |  Author(s): G. Wang, C. Zhang, H. Liu, Z. Yu, H. Liu

      • Abstract

      Loading...

    • +

      P018 - Afatinib Named Patient Use Program in Advanced NSCLC with Progression on Prior Therapy: Experience from Asian Centers (ID 93)

      00:00 - 00:00  |  Author(s): G. Chang, D.C. Lam, C. Tsai, Y. Chen, J. Shih, S. Aggarwal, S. Wang, S. Kim, Y. Kim, I. Wahid, R. Li, W. Lim, V. Sriuranpong, T.T. Chan, J.C. Yang, C. Yu, W. Liao, C. Ho, R.M. Lorence, P. Carriere, C. Raabe, A. Cseh, K. Park

      • Abstract

      Loading...

    • +

      P020 - Characterization of Met Exon 14 Skipping and Association with Clinical Outcomes of Crizotinib in Chinese Lung Cancers (ID 192)

      00:00 - 00:00  |  Author(s): H. Yang, C. Zhou, Y. Su, Z. Zhou, P. Chen, M. Yang, C. Li, W. Guo, W. Zhao, K. Lu, J. Yin, J. Chen, Z. Li, X. Yu, X. Xu, J. Xiang, T. Zhang, B. Li, L. Zhang, H. Liu, N. Yang

      • Abstract

      Loading...

    • +

      P021 - The Impact of TP53 Mutation and Tumor Mutation Number on Outcomes in Patients with Stage I Non (ID 168)

      00:00 - 00:00  |  Author(s): S. Zheng, J. Xia, F. Zeng, L. Huang, F. Li, H. Zhu, G. Liao, Z. Lin, H. Zhou

      • Abstract

      Loading...

    • +

      P022 - Association Between Oral Leukoplakia and Lung Cancer: A 28-Year Follow-Up Study in the Linxian General Population Trial (ID 145)

      00:00 - 00:00  |  Author(s): H. Liang, J. Wang, J. Fan, Y. Qiao

      • Abstract

      Loading...

    • +

      P023 - Factors associated with administration of subsequent cytotoxic chemotherapy after nivolumab in patients with advanced NSCLC (ID 164)

      00:00 - 00:00  |  Author(s): H. Jo, H. Horinouchi, R. Higashiyama, N. Tamura, S. Yagishita, Y. Matsumoto, S. Murakami, Y. Goto, S. Kanda, Y. Fujiwara, N. Yamamoto, Y. Ohe

      • Abstract

      Loading...

    • +

      P024 - Sleeve Lobectomy for Centrally Located Non-Small Cell Lung Cancer: Experience of a Single Institute (ID 111)

      00:00 - 00:00  |  Author(s): H. Liu, Y. Ma, Z. Yu, Y. Ren, C. Zhang, G. Wang, H. Liu

      • Abstract

      Loading...

    • +

      P025 - Which Is the Optimal Immunotherapy for Advanced Non-Squamous Non-Small-Cell Lung Cancer in Combination with Chemotherapy? (ID 222)

      00:00 - 00:00  |  Author(s): H Zhou

      • Abstract

      Loading...

    • +

      P026 - Impact of Prior Cancer History on the Overall Survival of Younger Patients with Lung Cancer (ID 202)

      00:00 - 00:00  |  Author(s): H. Zhou, Y. Zhang, J. Liu, G. Chen, Z. Zhang, L. Zhang

      • Abstract

      Loading...

    • +

      P028 - A Novel Method for Detecting Surface PD-L1 on Circulating Tumor Cells in Peripheral Blood of Patients with SCLC (ID 135)

      00:00 - 00:00  |  Author(s): D. Zhao, H. Li, Y. Liu, Y. Liu, J. Liu, Y. Cheng

      • Abstract

      Loading...

    • +

      P029 - Circulating MDSCs Derived from Small Cell Lung Cancer Patients Secrete TGF - Beta 1 and Play Roles in Angiogenesis (ID 151)

      00:00 - 00:00  |  Author(s): S. Lan, H. Li, Y. Liu, D. Zhao, S. Yan, T. Tian, Y. Cheng

      • Abstract

      Loading...

    • +

      P030 - Prognostic Factors for Advanced Lung Adenocarcinoma Patients Who Received Tyrosine Kinase Inhibitor and Radiotherapy (ID 94)

      00:00 - 00:00  |  Author(s): H. Yang, B. Chen, Y. Wang, Y. Gong, Y. Xu, L. Zhou, Y. Liu, Y. Lu

      • Abstract

      Loading...

    • +

      P032 - Integrin Subunit Alpha 5: Potential Prognostic Biomarker in Lung Adenocarcinoma (ID 103)

      00:00 - 00:00  |  Author(s): J.H. Hong

      • Abstract

      Loading...

    • +

      P033 - A Fusion-Protein Approach Enabling Mammalian Cell Production of Tumor Targeting Protein Domains for Therapeutic Development (ID 171)

      00:00 - 00:00  |  Author(s): J. Hu, Q. Zhou

      • Abstract

      Loading...

    • +

      P034 - A Case of Stage IIIA Thymoma Underwent Thymectomy with the Subxiphoid Approach (ID 34)

      00:00 - 00:00  |  Author(s): B. Aramini, J. Gening, J. Fan

      • Abstract

      Loading...

    • +

      P036 - Rechallenge Pemetrexed-Based Chemotherapy Provides an (ID 86)

      00:00 - 00:00  |  Author(s): J. Wang, X. Hu, Q. Qiao, Y. Liu, Z. Wang, J. Duan, Y. Feng, J. Wang

      • Abstract

      Loading...

    • +

      P037 - QSOX1/2 Regulates (ID 197)

      00:00 - 00:00  |  Author(s): Y. Li, C. Shi, J. Xiong

      • Abstract

      Loading...

    • +

      P038 - Docosapentaenoic Acid and Lung Cancer Risk: A Mendelian Randomisation Study (ID 54)

      00:00 - 00:00  |  Author(s): J. Liu, H. Zhou, Y. Zhang, Y. Huang, W. Fang, Y. Yang, S. Hong, G. Chen, S. Zhao, X. Chen, Z. Zhang, J. Shen, W. Xian, J. Zhan, Y. Zhao, X. Hou, Y. Ma, T. Zhou, H. Zhao, L. Zhang

      • Abstract

      Loading...

    • +

      P039 - Clinical Characteristics and Survival of Patients with Lymphoepithelioma-Like Carcinoma in Lung and Bronchus and Other Sites (ID 159)

      00:00 - 00:00  |  Author(s): J. Liu, X. Zhai, Y. Liu, L. Long, Q. Zhou, D. Lu

      • Abstract

      Loading...

    • +

      P040 - Highly Sensitivity and Fast Genetic Diagnosis by Mean of a Novel NGS-Based Resequencing Gene Panel Underlying SCLC Patients (ID 105)

      00:00 - 00:00  |  Author(s): J. Wang, L. Zhao, X. Sun, F. Zhou, Y. Zhang, S. Zhao, S. Liu, L. Chin, L. Wang, T. Guo, Z. Sun, F. Li, C. Gu

      • Abstract

      Loading...

    • +

      P041 - Different Recurrence Models in Lung Cancer Patients Between (ID 199)

      00:00 - 00:00  |  Author(s): J. Xia, S. Zheng, Q. Nie, S. Dong, W. Zhong

      • Abstract

      Loading...

    • +

      P042 - LincRNA00494 Suppresses Non-Small Cell Lung Cancer Cell Proliferation by Regulating SRCIN1 Expression in A ceRNA Manner (ID 182)

      00:00 - 00:00  |  Author(s): J. Dong, F. Xu, Q. Zhou

      • Abstract

      Loading...

    • +

      P043 - Cost-Effectiveness Analysis of Different Sequences of Osimertinib Administration for EGFR-Mutated Non-Small-Cell Lung Cancer (ID 35)

      00:00 - 00:00  |  Author(s): W. Li, L. Qian, W. Li, X. Chen, H. He, H. Tian, Y. Zhao, X. Wang, J. Cui

      • Abstract

      Loading...

    • +

      P044 - Cost-Effectiveness Analysis of Icotinib vs Whole-Brain Irradiation in NSCLC Patients with Brain Metastases (ID 122)

      00:00 - 00:00  |  Author(s): W. Li, R. Bai, L. Qian, N. Chen, Y. Zhao, F. Han, L. Bai, J. Li, Y. Yu, J. Cui

      • Abstract

      Loading...

    • +

      P045 - Prognostic Value of MHC-I, PD-L1 and CD8+ TILs Expressions in Patients with Surgically Resected Non-Small Cell Lung Cancer (ID 138)

      00:00 - 00:00  |  Author(s): X. Ding, J. Cui

      • Abstract

      Loading...

    • +

      P047 - Clinical Characteristics of the Surviving Lung Cancer Patients at Shanghai Chest Hospital During 2007- 2017 (ID 200)

      00:00 - 00:00  |  Author(s): Y. Zhao, Y. Yao, Z. Cheng

      • Abstract

      Loading...

    • +

      P049 - Neurocognitive Functions Before Radiotherapy for Brain Metastasis from Lung Cancer: An Analysis of 74 Cases (ID 97)

      00:00 - 00:00  |  Author(s): J. Zhen, Z. Peng, S. Li, M. Lai, L. Cai

      • Abstract

      Loading...

    • +

      P050 - Long-Term Survival of Stage IIIA-N2 NSCLC Patients with Interstitial Lung Diseases (ID 210)

      00:00 - 00:00  |  Author(s): J. Watanabe, H. Horinouchi, Y. Shinno, S. Murakami, Y. Goto, S. Kanda, Y. Fujiwara, N. Yamamoto, Y. Nakamura, S. Watanabe, Y. Ohe

      • Abstract

      Loading...

    • +

      P051 - A Novel (ID 176)

      00:00 - 00:00  |  Author(s): K. Yin, Y. Li, M. Zheng, B. Jiang, W. Li, J. Yang, H. Tu, Q. Zhou, W. Zhong, X. Yang, H. Yan, L. Li, Y. Wu, X. Zhang

      • Abstract

      Loading...

    • +

      P052 - A Biomarker Study of Advanced Non-Small Cell Lung Cancer Using Ultra-High-Performance Liquid Chromatography-Mass Spectrometry (ID 177)

      00:00 - 00:00  |  Author(s): K. Zhang, Y. Liu, Q. Yang, Y. Liu, Y. Zeng, X. Hong, Y. Hu, J. Liang, L. Liu

      • Abstract

      Loading...

    • +

      P053 - The Potential of Assessing Blood Tumor Mutation Burden (bTMB) Using a Large Panel (ID 70)

      00:00 - 00:00  |  Author(s): K. Zhang, Y. Tang, X. Xu, S. Zhang, W. Tao, Z. Rao, F. Wu, S. An, J. Liu, J. Yang, T. Hou, L. Zhang, Y. Zhang, L. Liu

      • Abstract

      Loading...

    • +

      P054 - Applicability of the Lung-molGPA Index in NSCLC (ID 28)

      00:00 - 00:00  |  Author(s): K. Chen, X. Yu, Y. Fan

      • Abstract

      Loading...

    • +

      P057 - Pembrolizumab + (ID 16)

      00:00 - 00:00  |  Author(s): K.F. Ang, R.J. Villafuerte, E. Regala

      • Abstract

      Loading...

    • +

      P058 - Effects of Neoadjuvant Chemotherapy on the Expression (ID 82)

      00:00 - 00:00  |  Author(s): W. Sun

      • Abstract

      Loading...

    • +

      P061 - Real Clinical Practice of Using Immunotherapy In NSCLC Patients With EGFR Mutation (ID 201)

      00:00 - 00:00  |  Author(s): L. Shen, S. Lu

      • Abstract

      Loading...

    • +

      P063 - STE029 Overcomes EGFR-TKI Resistance in Human Lung Adenocarcinoma (ID 121)

      00:00 - 00:00  |  Author(s): L. Huang, Q. Zhou

      • Abstract

      Loading...

    • +

      P066 - A Phase I Study of Apatinib Combined with Pemetrexed and Carboplatin in Untreated EGFR-Negative Stage IV Non-Squamous NSCLC (ID 81)

      00:00 - 00:00  |  Author(s): M. Huang, Y. Gong, J. Zhu, Y. Qin, F. Peng, L. Ren, Z. Ding, Y. Liu, Y. Wang, Y. Lu

      • Abstract

      Loading...

    • +

      P068 - The Geriatric Nutritional Risk Index Predicts the Overall Survival in Geriatric Patients with Metastatic Lung Adenocarcinoma (ID 131)

      00:00 - 00:00  |  Author(s): M. Tang, L. Li

      • Abstract

      Loading...

    • +

      P069 - HOTAIR, A Long Non-Coding RNA, Is a Marker of Abnormal Cell Cycle Regulation in Lung Cancer (ID 68)

      00:00 - 00:00  |  Author(s): M. Liu, F. Ren, X. Li, H. Zhang, J. Chen

      • Abstract

      Loading...

    • +

      P070 - Pembrolizumab for Non-Small Cell Lung Cancer with Untreated Central Nervous System Metastases: A Case Report (ID 101)

      00:00 - 00:00  |  Author(s): M. Di, L. Zhang

      • Abstract

      Loading...

    • +

      P071 - Variants Distribution and Heterogeneity of Outcomes to Crizotinib in ALK-Rearranged Chinese Non-Small Cell Lung Cancers (ID 179)

      00:00 - 00:00  |  Author(s): N. Liang, P. Xing, Y. Su, X. Long, Y. Gao, P. Chen, Z. Zhang, J. Liu, B. Li, T. Zhang, X. Mao, L. Zhang, H. Liu

      • Abstract

      Loading...

    • +

      P072 - Low Detection Rate of EGFR Driver and T790M Mutation in Plasma by (ID 110)

      00:00 - 00:00  |  Author(s): O. Yuko, T. Yoshida, K. Asada, T. Oguri, N. Inui, S. Morikawa, K. Ito, T. Kimura, E. Kunii, T. Matsui, A. Kubo, T. Kato, J. Shindo, T. Tsuda, M. Okuno, T. Hida

      • Abstract

      Loading...

    • +

      P073 - Cbl-b Predicts Prognosis of NSCLC Patients and Affects PD-L1 Expression in A549 (ID 23)

      00:00 - 00:00  |  Author(s): P. Li, X. Yan, G. Zhang, M. Zhang, X. Zhang, J. Yang, Y. Chang, H. Wang, J. Ma, Z. Ma

      • Abstract

      Loading...

    • +

      P075 - Hippo-YAP Pathway Mediated Resistance to Crizotinib in ROS1-Positive Lung Cancer (ID 113)

      00:00 - 00:00  |  Author(s): P. Sun, H. Gao

      • Abstract

      Loading...

    • +

      P076 - A Lung Adenocarcinoma with Concomitant EGFR And De Novo MET Amplification Response Well to Combination of TKI And Bevacizumab (ID 193)

      00:00 - 00:00  |  Author(s): Q. Chu, J. Jiang, S. Huang, P. Zhang, Y. Chen, T. Zhang

      • Abstract

      Loading...

    • +

      P077 - miR-338-3p Promotes the Resistance of Non-Small Cell Lung Cancers To EGFR-TKI By Targeting PTPN12 (ID 186)

      00:00 - 00:00  |  Author(s): Q. Wu, F. Guo, Y. Li, W. Li, G. Ma, Y. Deng, W. Luo, Y. Zhao, F. Xu, Q. Zhou

      • Abstract

      Loading...

    • +

      P080 - Efficacy and Safety of Docetaxel Plus Ramucirumab: A Consecutive Analysis of 68 Patients with Advanced NSCLC (ID 214)

      00:00 - 00:00  |  Author(s): S. Yokota, H. Horinouchi, S. Kanda, Y. Fujiwara, S. Murakami, Y. Goto, Y. Matsumoto, R. Morita

      • Abstract

      Loading...

    • +

      P081 - Clinical Characteristics and Molecular Patterns Of RET-Rearranged Lung Cancer in Chinese Patients (ID 191)

      00:00 - 00:00  |  Author(s): S. Fei, K. Zhang, H. Chen, Y. Wang, L. Yang, C. Zhou, W. Yin, G. Wang, B. Li, T. Zhang, J. Xiang, X. Mao

      • Abstract

      Loading...

    • +

      P082 - DNA Methylation: A More Sensitive Marker for Treatment Monitoring? (ID 78)

      00:00 - 00:00  |  Author(s): S. Xia, S. Chuai, Y. Chen, L. Huang, W. Deng, H. Han-Zhang, Y. Zhang, F. Xu, X. Ren, Y. Chen

      • Abstract

      Loading...

    • +

      P083 - Efficacy of EGFR-TKIs in Patients Harboring EGFR Mutations with Non-Adenocartinoma Histology (ID 223)

      00:00 - 00:00  |  Author(s): O Yuko

      • Abstract

      Loading...

    • +

      P084 - Musashi-2 Expression Is an (ID 148)

      00:00 - 00:00  |  Author(s): T. Wang, Q. Zhou, L. Luo

      • Abstract

      Loading...

    • +

      P086 - Toward the Standardization of Bioinformatics Methods for the Accurate Assessment of Tumor Mutational Burden (TMB) (ID 213)

      00:00 - 00:00  |  Author(s): H. Chang, S. Srinivasan, A. Sasson, R. Golhar, D. Greenawalt, S. Kirov, J. Szustakowski

      • Abstract

      Loading...

    • +

      P087 - TNM Staging Inversely Correlates with Age in ALK-positive Lung Cancer (ID 63)

      00:00 - 00:00  |  Author(s): W. Tang, C. Zhang, Y. Lei, R. Fu, J. Kang, H. Yan, X. Yang, H. Tu, Y. Wu, W. Zhong

      • Abstract

      Loading...

    • +

      P088 - Distribution of Different HER2 Mutations (ID 219)

      00:00 - 00:00  |  Author(s): W Wang

      • Abstract

      Loading...

    • +

      P089 - An EGFR KDD Data in the Chinese NSCLC Population and the Response to EGFR-TKIs: A Multicenter Study (ID 21)

      00:00 - 00:00  |  Author(s): W. Wang, C. Xu, Y. Zhu, M. Fang, W. Zhuang, Y. Chen, G. Chen, T. Lv, Y. Song

      • Abstract

      Loading...

    • +

      P090 - Prevalence of Brain Metastases in Limited Stage Small Cell Lung Cancer Immediately Before Prophylactic Cranial Irradiation (ID 22)

      00:00 - 00:00  |  Author(s): X. Chu, X. Yang, Z. Zhu

      • Abstract

      Loading...

    • +

      P091 - Association Between BIM Polymorphism and Lung Cancer Outcomes: A Meta-analysis (ID 24)

      00:00 - 00:00  |  Author(s): X. Li, L. Wu, H. Chen, Y. Zhu, W. Wang, C. Xu, X. Lin, D. Xie, K. Du

      • Abstract

      Loading...

    • +

      P093 - DNA Methylation in CTC And ctDNA is A Promising Marker for Early Detection of Lung Cancer Metastasis (ID 183)

      00:00 - 00:00  |  Author(s): X. Qiu, Q. Zhou

      • Abstract

      Loading...

    • +

      P094 - Evaluation of the Efficacy of Salvage Surgery for Advanced NSCLC Patients After Neoadjuvant (ID 102)

      00:00 - 00:00  |  Author(s): X. Cao, Y. Liao

      • Abstract

      Loading...

    • +

      P095 - MicroRNA-330-3p Promotes Brain Metastasis of Non-Small Cell Lung Cancer by Activating MAPK/MEK/ERK Signaling Through GRIA3 (ID 172)

      00:00 - 00:00  |  Author(s): C. Wei, Q. Cai, R. Zhang, F. Tong, X. Dong

      • Abstract

      Loading...

    • +

      P096 - MLPH Activates CDC42/PAK1 Signaling to Promote Epithelial (ID 173)

      00:00 - 00:00  |  Author(s): C. Wei, L. Peng, F. Tong, X. Dong

      • Abstract

      Loading...

    • +

      P097 - ctDNA Changes and TCR Diversity Associated with Clinical Outcomes Following Brain Therapy in NSCLC (ID 174)

      00:00 - 00:00  |  Author(s): C. Wei, L. Chen, X. Dong

      • Abstract

      Loading...

    • +

      P100 - Stem Cell Factor Leads to Lung Cancer Escapes from Anti-Angiogenic Therapy by Increasing the ALDH1+ Lung Cancer Cell Number (ID 146)

      00:00 - 00:00  |  Author(s): Y. Liu, L. Wang, F. Luo

      • Abstract

      Loading...

    • +

      P101 - Intratumor Heterogeneity Comparison Among Different Subtypes of (ID 206)

      00:00 - 00:00  |  Author(s): Y. Zhang, Y. Yang, W. Fang, L. Chang, L. Zhang, L. Zhang

      • Abstract

      Loading...

    • +

      P102 - The Correlations of Tumor Mutational Burden Among Single-region Tissue, Multi-region Tissues And Blood in NSCLC (ID 208)

      00:00 - 00:00  |  Author(s): Y. Zhang, W. Fang, Y. Yang, L. Chang, L. Zhang, L. Zhang

      • Abstract

      Loading...

    • +

      P104 - Anti-PD-1 Combination Therapy in Second or Later Lines in (ID 114)

      00:00 - 00:00  |  Author(s): F. Zhang, D. Huang, S. Cai, Y. Hu

      • Abstract

      Loading...

    • +

      P105 - Computational Design of IgG-like Tetra-specific Antibody Targeting EGFR/VEGF/PD-1/CTLA-4 Against NSCLC (ID 133)

      00:00 - 00:00  |  Author(s): Y. Hu, F. Zhang, S. Chen, L. Li, L. Zhao

      • Abstract

      Loading...

    • +

      P106 - The Efficacy and Safety of Bevacizumab Combined with Chemotherapy in the Treatment of Drug-Resistant SCLC (ID 153)

      00:00 - 00:00  |  Author(s): X. Liu, S. Wang

      • Abstract

      Loading...

    • +

      P107 - The Study of Relationship Between Tumor Burden (TMB) and Molecular Typing of Non-Small Cell Lung Cancer (NSCLC) (ID 127)

      00:00 - 00:00  |  Author(s): R. Zhong, H. Li, Y. Cheng

      • Abstract

      Loading...

    • +

      P109 - Combined Chemotherapy Versus Topotecan Monotherapy as Second-Line Treatment for Patients with Sensitive Relapsed SCLC (ID 160)

      00:00 - 00:00  |  Author(s): L. Zhang, X. Liu, Y. Cheng

      • Abstract

      Loading...

    • +

      P111 - Circulating Tumor Cells Combined Myeloid Derived Suppressor Cells Predict Prognosis of Advanced Small Cell Lung Cancer (ID 126)

      00:00 - 00:00  |  Author(s): Y. Liu, H. Li, D. Zhao, Y. Cheng

      • Abstract

      Loading...

    • +

      P112 - Significance of Low Expression of Tumor Associated Gene ki67 in Recurrence of Small Cell Lung Cancer (ID 165)

      00:00 - 00:00  |  Author(s): X. Zhang, L. Ma, Y. Hao, X. Zuo, Y. Cheng

      • Abstract

      Loading...

    • +

      P113 - Icotinib Alone or with Radio Therapy Inpatients with EGFR Mutations Non-Small Cell Lung Cancer Who Develop Brain Metastases (ID 120)

      00:00 - 00:00  |  Author(s): Y. Xin

      • Abstract

      Loading...

    • +

      P114 - Whole-Exome Sequencing (ID 118)

      00:00 - 00:00  |  Author(s): Y. Xu, Y. Cai, K. Ma, X. Wang

      • Abstract

      Loading...

    • +

      P115 - Clinical Outcome of Crizotinib in Diverse ALK Fusion Partners and Different Detection Methods Treatment Na (ID 129)

      00:00 - 00:00  |  Author(s): Y. Zhang, L. Zeng, N. Yang, Y. Li

      • Abstract

      Loading...

    • +

      P116 - Real World Data of 1st Line A+T in Advanced EGFR+ NSCLC: Clinical Outcome, PFS Influential Factors and Acquired Resistance (ID 132)

      00:00 - 00:00  |  Author(s): Y. Zhang, L. Zeng, N. Yang, Y. Li, D. Hu

      • Abstract

      Loading...

    • +

      P117 - MET 14 Skipping Mutation in Pulmonary Sarcomatoid Carcinoma Using Reverse Transcription Polymerase Chain Reaction Method (ID 20)

      00:00 - 00:00  |  Author(s): Y. Zhu, C. Xu, W. Wang, Y. Chen, M. Fang, Z. Gong, G. Chen

      • Abstract

      Loading...

    • +

      P119 - Impact of Treatment Modality on Long-Term Survival of Small-Cell Lung Cancer with IA Stage: a Population-based Study (ID 39)

      00:00 - 00:00  |  Author(s): Y. Zheng, H. Liao, H. Zhou, X. Xue, C. Wu, J. Zhao

      • Abstract

      Loading...

    • +

      P120 - How to Become Exsomes As Messengers and Sentinels to Influence Lung Cancer Growing? (ID 44)

      00:00 - 00:00  |  Author(s): Z. Yu

      • Abstract

      Loading...

    • +

      P121 - Clinical Value of Local Therapy in Advanced Crizotinib-Treated ALK-Rearranged Lung Cancer: Pattern of Failure Analyses (ID 19)

      00:00 - 00:00  |  Author(s): J. Ni, G. Li, Z. Zhu

      • Abstract

      Loading...

  • +

    Best abstracts selected from submissions 1 (ID 1)

    • Type: Oral Session
    • Track:
    • Presentations: 2
  • +

    Best abstracts selected from submissions 2 (ID 2)

    • Type: Oral Session
    • Track:
    • Presentations: 2
  • +

    Best abstracts selected from submissions 3 (ID 3)

    • Type: Oral Session
    • Track:
    • Presentations: 2
    • +

      OA05 - Tumor Mutational Burden Standardization Initiative: Establish a Consistent Methodology for TMB Measurement in Clinical Samples (ID 217)

      06:20 - 06:30  |  Author(s): F Yan

      • Abstract

      Loading...

    • +

      OA06 - Tepotinib in Non-Small Cell Lung Cancer with MET Exon 14-Skipping Mutations or MET Amplification: (ID 140)

      06:30 - 06:40  |  Author(s): P. Paik, H. Sakai, R. Bruns, J. Scheele, J. Straub, E. Felip

      • Abstract

      Loading...

  • +

    Parallel Session 1 - Biomarker detecting for lung cancer: new technique and new opinion (ID 1002)

    • Type: Oral Session
    • Track:
    • Presentations: 3
    • Slides Available
    • +

      Discussant - Sequencing or Combination? (Slides Available) (ID 2006)

      06:40 - 07:00  |  Author(s): J Hu

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Standardization of molecular testing in China (Slides Available) (ID 2005)

      04:50 - 05:15  |  Author(s): X Zhang

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      What is a trustworthy biomarker? (Slides Available) (ID 2004)

      04:25 - 04:50  |  Author(s): C Manegold

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    Parallel Session 2 - Brain metastases and Leptomeningeal metastasis (ID 1003)

    • Type: Oral Session
    • Track:
    • Presentations: 3
    • Slides Available
    • +

      Can this drug penetrate the brain? (Slides Available) (ID 2008)

      20:50 - 21:15  |  Author(s): F Kong

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Diagnosis and management of leptomeningeal metastasis (Slides Available) (ID 2009)

      05:15 - 05:40  |  Author(s): J Yang

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Optimal radiotherapy for CNS metastasis in patients with a driver oncogene (Slides Available) (ID 2007)

      20:25 - 20:50  |  Author(s): Y Lu

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    Parallel Session 3 - Tobacco control, Staging and cancer prevention in Asia (ID 1004)

    • Type: Oral Session
    • Track:
    • Presentations: 1
    • Slides Available
    • +

      Tobacco control in China (Slides Available) (ID 2010)

      04:00 - 04:20  |  Author(s): X Zhi

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    Plenary Session - Past, Present and Future of Targeted Therapy in NSCLC (ID 1001)

    • Type: Oral Session
    • Track:
    • Presentations: 3
    • Slides Available
    • +

      Clinical application of ctDNA in management of oncogenic driven lung cancer (Slides Available) (ID 2003)

      09:05 - 09:30  |  Author(s): S Lu

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Optimal sequence of EGFR TKI (Slides Available) (ID 2001)

      08:15 - 08:40  |  Author(s): T Mok

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Optimal sequence of ALK TKI (Slides Available) (ID 2002)

      08:40 - 09:05  |  Author(s): I Ou

      • Abstract
      • Slides

      Abstract not provided

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    Best abstracts selected from submissions 4 (ID 4)

    • Type: Oral Session
    • Track:
    • Presentations: 2
    • Slides Available
  • +

    Best abstracts selected from submissions 5 (ID 6)

    • Type: Oral Session
    • Track:
    • Presentations: 2
    • Slides Available